Related Experiment Video

Updated: May 21, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Acquired peripheral neuropathy: a report on 20 children

P Pavone, A D Praticò, M Ruggieri

    International Journal of Immunopathology and Pharmacology
    |June 16, 2012
    PubMed

    Insights

    Guillain-Barré syndrome (GBS) is an inflammatory nerve disorder in children. This study reviews 20 pediatric cases, focusing on epidemiology, clinical presentation, and treatment.

    Area of Science:

    • Neurology
    • Pediatrics
    • Immunology

    Background:

    • Guillain-Barré syndrome (GBS) is an acute inflammatory polyneuropathy affecting children.
    • It presents with rapid onset of symmetric muscle weakness, pain, and sensory disturbances.
    • GBS incidence in children is 0.8 per 100,000, often following infections or vaccinations.

    Discussion:

    • The etiopathogenesis of GBS is thought to involve immune-mediated attacks on peripheral nerves.
    • This case series analyzes epidemiologic, clinical, and therapeutic data from 20 pediatric patients.
    • Understanding these features is crucial for timely diagnosis and management.

    Key Insights:

    • Pediatric GBS exhibits distinct epidemiological and clinical patterns.
    • Infectious triggers and vaccination are common preceding events.
    • Early recognition and appropriate management are vital for patient outcomes.

    Outlook:

    • Further research into GBS pathogenesis can refine treatment strategies.
    • Long-term follow-up of pediatric GBS patients is essential.
    • Investigating the specific immune mechanisms may lead to targeted therapies.

    Related Concept Videos

    Diabetic Neuropathy01:22

    Diabetic Neuropathy

    DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
    Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

    Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

    Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Peripheral Artery Disease I: Introduction01:30

    Peripheral Artery Disease I: Introduction

    Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...